000			03100nam a22004215i 4500
999			_c6139 _d6139
001			6139
003			ES-MaUEC
005			20201203160809.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			191023s2020 gw | s |||| 0|eng d
020			_a9783030256104
024	7		_a10.1007/978-3-030-25610-4 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
041	0		_aeng
050		4	_aRC280 _b.L9 2020 EB
245	0	0	_aNovel Therapeutics for Rare Lymphomas _cedited by Christopher Dittus
250			_aFirst edition
264		1	_aCham _bSpringer International Publishing : _bImprint: Springer _c2020
300			_a1 recurso en línea (X, 253 páginas) _b 22 ilustraciones, 20 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
490	0		_aMedicine (Springer-11650)
505	0		_aThe Hematopathology and Diagnostic Challenges of Rare Lymphomas -- Novel Therapeutics in the Management of Waldenstrom Macroglobulinemia -- Immunotherapy in Hodgkin Lymphoma and other CD30+ Lymphomas -- Chronic Lymphocytic Leukemia with Alterations in TP53 -- Mantel Cell Lymphoma -- Current and Emerging Treatment Strategies from Primary Mediastinal B-Cell Lymphoma -- Plasmablastic Lymphoma and Primary Effusion Lymphoma -- Novel Agents in Primary Central Nervous System Lymphoma -- Adult T-Cell Leukemia/Lymphoma -- Extranodal NK/T-Cell Lymphoma -- Anaplastic Large Cell Lymphoma -- Enteropathy-Associated T-Cell Lymphomas -- Hepatosplenic T-Cell Lymphoma -- Cutaneous T-Cell Lymphoma: Mycosis Fungoides and Sezary Syndrom.
520	3		_aThis comprehensive volume reviews the clinical presentation, diagnosis, and treatment approach to rare lymphomas. There is particular emphasis placed on new diagnostic approaches, novel chemotherapy combinations, and treatment modalities with novel therapeutics. It highlights research advances in a group of diseases that are often overlooked, and serves as a single repository of information on the most recent advances in targeted small molecule inhibitors, monoclonal antibodies, immunotherapy, and CAR-T therapy as they pertain to rare types of lymphoma. Written for practicing oncologists, hematologists, fellows, and residents, Novel Therapeutics for Rare Lymphomas covers rare subtypes of lymphoma, including indolent and aggressive T-cell lymphomas and B-cell lymphomas.
650		7	_2embne _9668066 _aLinfomas
650		7	_2embne _9672611 _aLinfomas _xTratamiento
700	1		_aDittus, Christopher. _eeditor _4edt _4http://id.loc.gov/vocabulary/relators/edt
710	2		_aSpringerLink (Online service) _9106937
776	0	8	_iPrinted edition: _z9783030256098
776	0	8	_iPrinted edition: _z9783030256111
776	0	8	_iPrinted edition: _z9783030256128
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-25610-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942			_2lcc _cLE _n0
998			_db _zSI